CrowdStrike Holdings, Inc. ⋅ 10-Q ⋅ 6/4 CIENA CORP ⋅ 10-Q ⋅ 6/4 Keysight Technologies, Inc. ⋅ 10-Q ⋅ 6/4 DICK'S SPORTING GOODS, INC. ⋅ 10-Q ⋅ 6/4 lululemon athletica inc. ⋅ 10-Q ⋅ 6/4 PERSHING SQUARE INC. ⋅ 10-Q ⋅ 6/4 FIVE BELOW, INC ⋅ 10-Q ⋅ 6/4 X-Energy, Inc. ⋅ 10-Q ⋅ 6/4 ARGAN INC ⋅ 10-Q ⋅ 6/4 TORO CO ⋅ 10-Q ⋅ 6/4

CrowdStrike Holdings, Inc. ⋅ 10-Q ⋅ 6/4 CIENA CORP ⋅ 10-Q ⋅ 6/4 Keysight Technologies, Inc. ⋅ 10-Q ⋅ 6/4 DICK'S SPORTING GOODS, INC. ⋅ 10-Q ⋅ 6/4 lululemon athletica inc. ⋅ 10-Q ⋅ 6/4 PERSHING SQUARE INC. ⋅ 10-Q ⋅ 6/4 FIVE BELOW, INC ⋅ 10-Q ⋅ 6/4 X-Energy, Inc. ⋅ 10-Q ⋅ 6/4 ARGAN INC ⋅ 10-Q ⋅ 6/4 TORO CO ⋅ 10-Q ⋅ 6/4

Royalty Pharma plc

Pharmaceutical Preparations | SIC: 2834
Phone: (212) 883-0200

CIK: 0001802768
State Location: NY
State of Inc.: X0

Nasdaq:RPRX

Form: 144

Filing Date: 14 May 2026
Report Date:
Accepted: 14 May 2026 03:28 p.m.
Accession Number: 0001964306-26-000240

Act: 33
File Number: 001-39329
Film Number: 26980631

Documents

Primary Document

Accepted: 14 May 2026 03:28 p.m.

0001964306-26-000240-index-headers.html

Last Modified: 14 May 2026 03:28 p.m.

0001964306-26-000240-index.html

Last Modified: 14 May 2026 03:28 p.m.

0001964306-26-000240.txt

Last Modified: 14 May 2026 03:28 p.m.

primary_doc.xml

Last Modified: 14 May 2026 03:28 p.m.